evaluation of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol , the primary psychoactive cannabinoid component of marijuana , comprises one of several very active areas of cannabinoid clinical research .
C0039663
delta-9-tetrahydrocannabinol
C0006864
cannabinoid